Evidence map›Paper›PMID 33431908›Full record

ArticleNature communications2021

In situ NMR reveals real-time nanocrystal growth evolution via monomer-attachment or particle-coalescence.

Reut Mashiach, Haim Weissman, Liat Avram, Lothar Houben, Olga Brontvein, Anna Lavie, Vaishali Arunachalam, Michal Leskes, Boris Rybtchinski, Amnon Bar-Shir

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. DiffusionNano letters · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Reut MashiachDepartment of Organic Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Haim WeissmanDepartment of Organic Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Liat AvramDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Lothar HoubenDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Olga BrontveinDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Anna LavieDepartment of Materials and Interfaces, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Vaishali ArunachalamDepartment of Materials and Interfaces, Weizmann Institute of Science, Rehovot, 7610001, Israel.
Michal LeskesDepartment of Materials and Interfaces, Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0002-7172-9689
Boris RybtchinskiDepartment of Organic Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel.ORCID 0000-0002-2071-8429
Amnon Bar-ShirDepartment of Organic Chemistry, Weizmann Institute of Science, Rehovot, 7610001, Israel. amnon.barshir@weizmann.ac.il.ORCID 0000-0003-1431-0221
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding inorganic nanocrystal (NC) growth dynamic pathways under their native fabrication environment remains a central goal of science, as it is crucial for rationalizing novel nanoformulations with desired architectures and functionalities. We here present an in-situ method for quantifying, in real time, NCs' size evolution at sub-nm resolution, their concentration, and reactants consumption rate for studying NC growth mechanisms. Analyzing sequential high-resolution liquid-state

Identifiers

PMID33431908
PMCPMC7801738
OpenAlexW3119775236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.